» Articles » PMID: 32519037

Psychological Flexibility, Pain Characteristics and Risk of Opioid Misuse in Noncancerous Chronic Pain Patients

Overview
Publisher Springer
Specialty Psychology
Date 2020 Jun 11
PMID 32519037
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To our knowledge, this is the first study exploring psychological flexibility and its association with pain severity, pain interference and risk of opioid misuse in chronic pain patients.

Methods: Data were collected at two outpatient pain clinics in the northeastern United States. Adults (N = 99) completed a cross-sectional survey with validated measures. Pain severity and pain interference were hypothesized to uniquely predict the risk of opioid misuse. Pain severity was hypothesized to predict pain interference. Finally, psychological flexibility was hypothesized as an indirect effect in these relationships.

Results: Main findings suggest that pain severity predicts risk of opioid misuse, mediated by psychological flexibly. Pain interference also predicts risk of opioid misuse, mediated by psychological flexibility. Finally, results suggest pain severity predicts pain interference, mediated by psychological flexibility.

Discussion: Implications of findings are discussed in terms of future psychological and medical assessments and interventions for chronic pain patients seeking prescription opioids.

Citing Articles

Experiential Avoidance, Pain, and Suicide Risk in a National Sample of Gulf War Veterans.

Grove J, Young J, Chen Z, Blakey S, Beckham J, Calhoun P Arch Suicide Res. 2022; 28(1):295-309.

PMID: 36573028 PMC: 10291004. DOI: 10.1080/13811118.2022.2160681.


Which outcome variables are associated with psychological inflexibility/flexibility for chronic pain patients? A three level meta-analysis.

Fang S, Ding D Front Psychol. 2022; 13:1069748.

PMID: 36562078 PMC: 9767366. DOI: 10.3389/fpsyg.2022.1069748.


Associations Between Six Core Processes of Psychological Flexibility and Functioning for Chronic Pain Patients: A Three-Level Meta-Analysis.

Ding D, Zheng M Front Psychiatry. 2022; 13:893150.

PMID: 35898622 PMC: 9309299. DOI: 10.3389/fpsyt.2022.893150.


Pain Acceptance Creates an Emotional Context That Protects against the Misuse of Prescription Opioids: A Study in a Sample of Patients with Chronic Noncancer Pain.

Esteve R, Marcos E, Reyes-Perez A, Lopez-Martinez A, Ramirez-Maestre C Int J Environ Res Public Health. 2021; 18(6).

PMID: 33809628 PMC: 8002364. DOI: 10.3390/ijerph18063054.


Opioid Pain Medication Prescription for Chronic Pain in Primary Care Centers: The Roles of Pain Acceptance, Pain Intensity, Depressive Symptoms, Pain Catastrophizing, Sex, and Age.

Ramirez-Maestre C, Reyes-Perez A, Esteve R, Lopez-Martinez A, Bernardes S, Jensen M Int J Environ Res Public Health. 2020; 17(17).

PMID: 32899359 PMC: 7503487. DOI: 10.3390/ijerph17176428.

References
1.
Bernstein D, Fink L, Handelsman L, Foote J, Lovejoy M, Wenzel K . Initial reliability and validity of a new retrospective measure of child abuse and neglect. Am J Psychiatry. 1994; 151(8):1132-6. DOI: 10.1176/ajp.151.8.1132. View

2.
Boscarino J, Hoffman S, Han J . Opioid-use disorder among patients on long-term opioid therapy: impact of final DSM-5 diagnostic criteria on prevalence and correlates. Subst Abuse Rehabil. 2015; 6:83-91. PMC: 4548725. DOI: 10.2147/SAR.S85667. View

3.
Butler S, Budman S, Fernandez K, Jamison R . Validation of a screener and opioid assessment measure for patients with chronic pain. Pain. 2004; 112(1-2):65-75. DOI: 10.1016/j.pain.2004.07.026. View

4.
Chakrabarti A, Woody G, Griffin M, Subramaniam G, Weiss R . Predictors of buprenorphine-naloxone dosing in a 12-week treatment trial for opioid-dependent youth: secondary analyses from a NIDA Clinical Trials Network study. Drug Alcohol Depend. 2009; 107(2-3):253-6. PMC: 2821971. DOI: 10.1016/j.drugalcdep.2009.10.014. View

5.
Caldwell J, Rapoport R, Davis J, Offenberg H, Marker H, Roth S . Efficacy and safety of a once-daily morphine formulation in chronic, moderate-to-severe osteoarthritis pain: results from a randomized, placebo-controlled, double-blind trial and an open-label extension trial. J Pain Symptom Manage. 2002; 23(4):278-91. DOI: 10.1016/s0885-3924(02)00383-4. View